The Advisory Committee on Immunization Practices recently released its 2018 adult immunization schedule, which included new recommendations advocating for the use of Shingrix for the prevention of ...

PHILADELPHIA, July 17, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster ...

European Commission approves GSK’s recombinant zoster vaccine, Shingrix in prefilled syringe: London, UK Thursday, January 8, 2026, 09:00 Hrs [IST] GSK plc announced the Europea ...

Shingrix, a recombinant zoster vaccine, combines glycoprotein E antigen with an adjuvant system called AS01B. It has been ...

Consumer Reports has no financial relationship with advertisers on this site. Today, the Centers for Disease Control and Prevention made its formal recommendations for the use of Shingrix—a new ...

Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout. While Shingrix sales are churning ahead of ...

(Alliance News) - GSK PLC on Wednesday reported positive developments with its shingles vaccine and its potential treatment for chronic hepatitis B, as it secured a presentation approval and announced ...

If you’re 50 or older, Judith Strull's story might sound familiar. Told by her doctor last month to get the new shingles vaccine, Shingrix, she went to her local CVS in Newton, Mass., expecting a ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...

GSK has received the Food and Drug Administration’s approval for a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster).